Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
Related Posts
Disney and Universal sue AI image company Midjourney for unlicensed use of Star Wars, The Simpsons and more
Disney and Universal have sued artificial intelligence image creator Midjourney, alleging copyright infringement, according to court filings.
It will be a high stakes Black Friday. These are the retail stocks you want to own this holiday season
Frenzied shopping on Black Friday will prove make-or-break for stores, and dividing lines will distinguish between the winners and losers in the retail sector.
UK autos spared under U.S. tariff cut but steel still in question
Britain was the first country in the world to make a deal with the White House after U.S. President Donald Trump unveiled his reciprocal tariffs […]